| 000 | 01459 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514210502.0 | ||
| 264 | 0 | _c20050217 | |
| 008 | 200502s 0 0 eng d | ||
| 022 | _a0304-4602 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAkdeniz, N | |
| 245 | 0 | 0 |
_aSerum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease. _h[electronic resource] |
| 260 |
_bAnnals of the Academy of Medicine, Singapore _cSep 2004 |
||
| 300 |
_a596-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBehcet Syndrome _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xblood |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitric Oxide _xblood |
| 650 | 0 | 4 | _aProbability |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
| 700 | 1 | _aEsrefoglu, M | |
| 700 | 1 | _aKeleş, M S | |
| 700 | 1 | _aKarakuzu, A | |
| 700 | 1 | _aAtasoy, M | |
| 773 | 0 |
_tAnnals of the Academy of Medicine, Singapore _gvol. 33 _gno. 5 _gp. 596-9 |
|
| 999 |
_c15219518 _d15219518 |
||